Wednesday, 31 July 2019

Amgen results beat estimates, lung cancer trial planned

Amgen said its second-quarter revenue fell 3% due to more competition for its older off-patent drugs.

from Earnings https://ift.tt/2YuJ9aY
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)